Prescribing Patterns Amongst UK Dermatologists for the Treatment of Alopecia Areata, Female Pattern Hair Loss, and Frontal Fibrosing Alopecia

    October 2024 in “ JEADV Clinical Practice ”
    John Frewen, Dalia Saidely Alsaadi, Leila Asfour, Sharon Belmo, Alyson Bryden, Caroline Champagne, Nicola A. Clayton, N Cooke, Donna Cummins, David Fairhurst, Paul Farrant, G. Hale, Susan Holmes, Thomas Harries, Ruth Ellen Jones, S. Karanovic, Manjit R. Kaur, Nekma Meah, Megan Mowbray, Archana Rao, Nasim Rouhani, Nicola Salmon, Anita Takwale, Martin Wade, Sharon L. Wong, Shirin Zaheri, Yusur Al‐Nuaimi, Matthew Harries
    Image of study
    TLDR UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.
    This study investigates the prescribing patterns of UK dermatologists for alopecia areata (AA), female pattern hair loss (FPHL), and frontal fibrosing alopecia (FFA), revealing significant variability in treatment approaches. For mild-moderate AA, topical corticosteroids are commonly used, while oral corticosteroids are preferred for severe cases. Intralesional corticosteroids are considered most effective by 82% of the 26 dermatologists surveyed. The study highlights the introduction of JAK inhibitors as a significant development, though their role in treatment remains unclear. For FPHL, topical minoxidil is the most common first-line treatment, with oral minoxidil deemed most effective. FFA treatments vary widely, indicating uncertainty about their efficacy. Access to certain treatments is often limited to private practice, affecting treatment equity. The findings emphasize the need for better evidence and real-world data to guide treatment decisions and inform policy, particularly regarding the potential NHS approval of JAK inhibitors for AA.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community How essential is scalp biopsy when dealing with hair loss?

      in Treatment  6 upvotes 1 year ago
      The user experienced hair loss despite using Fin and Min for 12 years and switched to Dutasteride, RU58841, and Keto scalp serum, but shedding and itch persist. They are considering increasing Dutasteride to 2.5mg and questioning the necessity of a scalp biopsy, with mixed opinions on its usefulness.

      community So we’re just ok with taking a research chemical now?

      in Treatment  178 upvotes 5 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 3 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

    Related Research

    4 / 4 results